James Cavuoto from Neurotech Reports offers insight into the retinal market in his column you can read here.
The market for retinal prostheses, once thought to be a far-off possibility, is now a reality. Industry pioneer Second Sight Medical Products, a spinoff from the Alfred Mann Foundation, has achieved its first $1 million in product revenue in Europe and may well be on the market in the U.S. in a matter of months if its HDE application is approved by the FDA [see vendor profile, p6]. Though we’ve learned never to take FDA approval for granted, we’d be surprised to see the agency delay this application, given that blind people in Europe already have this device and given CDRH’s recent commitment to a more reasonable approval process.
To read all of what Cavuoto has to say for this market, click here.